StockNews.AI

INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

StockNews.AI • 4 hours

RMDIVFAIVFSHMPFERT
High Materiality8/10

Information

SARASOTA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the ...

Original source

AI Summary

INVO Fertility will participate in an investor summit via webcast. They focus on expanding ART access through clinics and innovative technologies. INVOcell allows fertilization within the woman's body, making processes affordable. The IVC procedure offers effective fertility treatment compared to traditional methods. INVO operates two centers in the U.S. and distributes INVOcell widely.

Sentiment Rationale

INVO's unique IVC offering could capture more market share, similar to how fertility tech firms benefited from trends in ART.

Trading Thesis

As awareness of the IVC innovation spreads, its demand is likely to grow significantly over time.

Market-Moving

  • INVO Fertility will participate in an investor summit via webcast.
  • They focus on expanding ART access through clinics and innovative technologies.
  • INVOcell allows fertilization within the woman's body, making processes affordable.

Key Facts

  • INVO Fertility will participate in an investor summit via webcast.
  • They focus on expanding ART access through clinics and innovative technologies.
  • INVOcell allows fertilization within the woman's body, making processes affordable.
  • The IVC procedure offers effective fertility treatment compared to traditional methods.
  • INVO operates two centers in the U.S. and distributes INVOcell widely.

Companies Mentioned

  • RMD (RMD)
  • IVF (IVF)
  • AIVF (AIVF)
  • SHMP (SHMP)
  • FERT (FERT)

Corporate Developments

The article details key innovations and strategies that could enhance INVO’s competitive advantage in the fertility market.

INVO Fertility to Participate in Lytham Partners 2026 Investor Healthcare Summit

SARASOTA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF), a leader in healthcare fertility services, has announced its participation in a webcast fireside chat at the Lytham Partners 2026 Investor Healthcare Summit. The event is set to take place virtually on Thursday, January 15, 2026, at 3:00 p.m. ET.

Webcast Details and Access

Investors and interested parties can access the live webcast by visiting the conference home page at https://lythampartners.com/hc2026/ or directly at https://lythampartners.com/hc2026/ivf. A replay of the session will also be available on the same links post-event.

About INVO Fertility

INVO Fertility is primarily focused on expanding accessibility to assisted reproductive technology (ART) through the establishment, acquisition, and operation of fertility clinics. The Company's strategy involves:

  • Building and operating INVO Centers that offer the intravaginal culture (IVC) procedure.
  • Operating US-based, profitable in vitro fertilization (IVF) clinics.
  • Engaging in the sale and distribution of the INVOcell medical device.

Currently, INVO Fertility operates two INVO Centers in the United States alongside one IVF clinic, effectively delivering patient-centered care within the fertility domain.

Innovative Technology and Patient Care

The INVOcell device is revolutionary, allowing fertilization and early embryo development to occur in vivo within a woman's body. This innovative method not only enhances the intimacy of the fertility experience but also offers a more affordable alternative to traditional ART treatments.

The IVC procedure aims to provide comparable results to traditional IVF methods, often at a significantly lower cost, positioning it as a more effective treatment option than intrauterine insemination.

Contact Information

For further inquiries, please contact:

Related News